News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,340 Results
Type
Article (13599)
Company Profile (110)
Press Release (247631)
Section
Business (87977)
Career Advice (461)
Deals (15331)
Drug Delivery (64)
Drug Development (36535)
Employer Resources (49)
FDA (6259)
Job Trends (6188)
News (150069)
Policy (14015)
Tag
Academia (435)
Alliances (23095)
Alzheimer's disease (352)
Approvals (6253)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4328)
Biotechnology (44)
Breast cancer (42)
Cancer (313)
Career advice (405)
Cell therapy (44)
Clinical research (30399)
Collaboration (154)
Compensation (62)
COVID-19 (747)
C-suite (52)
Data (342)
Diabetes (53)
Diagnostics (1237)
Drug pricing (57)
Earnings (31560)
Employer resources (43)
Events (36742)
Executive appointments (171)
FDA (6438)
Funding (104)
Gene therapy (60)
GLP-1 (292)
Government (1270)
Healthcare (3530)
Infectious disease (764)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5817)
Job creations (2050)
Job search strategy (372)
Layoffs (167)
Legal (3415)
Lung cancer (46)
Manufacturing (99)
Medical device (1263)
Medtech (1265)
Mergers & acquisitions (9548)
Metabolic disorders (166)
Neuroscience (450)
NextGen Class of 2024 (1585)
Non-profit (592)
Northern California (432)
Obesity (99)
Opinion (109)
Patents (52)
People (28472)
Pharmaceutical (64)
Phase I (7903)
Phase II (12855)
Phase III (11552)
Pipeline (183)
Policy (45)
Postmarket research (1400)
Preclinical (3165)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2632)
Regulatory (9821)
Research institute (562)
Resumes & cover letters (55)
Southern California (435)
Startups (1625)
United States (4255)
Vaccines (112)
Weight loss (78)
Date
Today (33)
Last 7 days (275)
Last 30 days (1244)
Last 365 days (12698)
2024 (11590)
2023 (14246)
2022 (19567)
2021 (20078)
2020 (19043)
2019 (14906)
2018 (11725)
2017 (13890)
2016 (13133)
2015 (15473)
2014 (12425)
2013 (10598)
2012 (11396)
2011 (11925)
2010 (10888)
Location
Africa (312)
Arizona (42)
Asia (19792)
Australia (2559)
California (1004)
Canada (598)
China (111)
Colorado (41)
Connecticut (41)
Europe (38780)
Florida (149)
Illinois (110)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (154)
Massachusetts (876)
Minnesota (56)
New Jersey (420)
New York (278)
North Carolina (277)
Northern California (432)
Pennsylvania (283)
South America (498)
Southern California (435)
Texas (138)
Virginia (40)
Washington State (70)
261,340 Results for "acadia pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Acadia Pharmaceuticals to Participate at Upcoming May 2024 Investor Conferences
Acadia Pharmaceuticals Inc. announced that it will participate at three upcoming investor conferences.
May 9, 2024
·
1 min read
Press Releases
Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview
November 7, 2024
·
13 min read
Biotech Beach
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 17, 2024
Acadia Pharmaceuticals Inc. announced that on May 15, 2024, the Compensation Committee of Acadia’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 57,252 shares of common stock and 33,675 restricted stock units to twenty-two new employees under Acadia’s 2023 Inducement Plan.
May 17, 2024
·
2 min read
Business
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the first quarter ended March 31, 2024.
May 8, 2024
·
11 min read
Business
Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024
October 17, 2024
·
1 min read
Press Releases
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 15, 2024
November 18, 2024
·
2 min read
Biotech Beach
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 19, 2024
Acadia Pharmaceuticals Inc. announced that on April 10, 2024, the Compensation Committee of Acadia’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common stock and 12,739 restricted stock units to six new employees under Acadia’s 2023 Inducement Plan.
April 19, 2024
·
2 min read
Press Releases
Acadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
November 6, 2024
·
3 min read
Business
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
April 24, 2024
·
1 min read
Press Releases
Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE™ (trofinetide) for the Treatment of Rett Syndrome
October 17, 2024
·
8 min read
1 of 26,134
Next
